NASDAQ:PODD
Insulet Corporation Stock News
$185.38
+4.82 (+2.67%)
At Close: May 16, 2024
Insulet (PODD) to Expand Base in Malaysia With New Facility
10:33am, Thursday, 02'nd Jun 2022
The new manufacturing facility by Insulet (PODD) is set to have approximately 400,000 square feet of manufacturing space.
Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference
06:01am, Thursday, 02'nd Jun 2022
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
Why DexCom Stock Is Jumping Today
03:12pm, Tuesday, 31'st May 2022 The Motley Fool
The company confirmed that it isn't in merger discussions with Insulet.
DexCom stock leads S&P 500's premarket gainers after denying merger talks, and Insulet stock drops
09:26am, Tuesday, 31'st May 2022
Shares of DexCom Inc. DXCM, +5.35% surged 8.1% to pace the S&P 500's SPX, -0.37% premarket gainers, after the diabetes care company said it was not currently in "active discussions" regarding a merger
Why Insulet Stock Is Soaring This Week
08:51pm, Thursday, 26'th May 2022 The Motley Fool
The company is reportedly in discussions with Dexcom about a potential merger.
Why Insulet Stock Is Soaring This Week
04:51pm, Thursday, 26'th May 2022
The company is reportedly in discussions with Dexcom about a potential merger.
Why DexCom Is Down More Than 11% on Tuesday
04:56pm, Tuesday, 24'th May 2022 The Motley Fool
Whispers of an acquisition aren't being well received by already nervous shareholders, who may be questioning the timing as well as the potential of such a deal.
PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition
10:52am, Tuesday, 24'th May 2022
Insulet (PODD) stock is heading higher on Tuesday as investors react to reports that DexCom (DXCM) is considering acquiring the company. The post PODD Stock Pops 7% as DexCom Considers Insulet Corpora
Insulet Stock Rises on Report of Dexcom Acquisition Talks
06:29am, Tuesday, 24'th May 2022
A potential deal could be announced in coming weeks, according to a Bloomberg report.
Citigroup Maintains Buy Rating for Insulet: Here's What You Need To Know
04:00pm, Tuesday, 17'th May 2022 Benzinga
Citigroup has decided to maintain its Buy rating of Insulet (NASDAQ:PODD) and lower its price target from $350.00 to $310.00.
Shares of Insulet are trading up 1.23% over the last 24 hours, at $199.34
10 Biggest Price Target Changes For Tuesday
12:23pm, Tuesday, 17'th May 2022 Benzinga
Citigroup cut the price target on Insulet Corporation (NASDAQ: PODD) from $350 to $310. Insulet shares fell 1.1% to close at $196.91 on Monday.
Morgan Stanley cut Rivian Automotive, Inc. (NASDAQ:
Insulet (PODD) Q1 Earnings Surpass Estimates, Margins Grow
03:06pm, Monday, 09'th May 2022 Zacks Investment Research
Robust adoption of Omnipod DASH and record new customer starts have contributed to Insulet's (PODD) Q1 performance.
Insulet (PODD) Q1 Earnings Surpass Estimates, Margins Grow
12:47pm, Monday, 09'th May 2022
Robust adoption of Omnipod DASH and record new customer starts have contributed to Insulet's (PODD) Q1 performance.
Insulet Corporation (PODD) CEO Shacey Petrovic on Q1 2022 Results - Earnings Call Transcript
05:23pm, Friday, 06'th May 2022
Insulet Corporation (NASDAQ:PODD ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Shacey Petrovic - President, CEO and
Expert Ratings for Insulet
05:02pm, Friday, 06'th May 2022 Benzinga
Within the last quarter, Insulet (NASDAQ:PODD) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
2
0
0
Last 30D
0
2
